ArticleFrontiers in cellular and infection microbiology2017

AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300.

Shengyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.